Recently, Bruton’s tyrosine kinase (BTK) has been reported to play a role in physiological inhibition of NLRP3 inflammasome activation, which explains why patients with X-linked agammaglobulinemia tend to develop Crohn’s disease (CD) [32]. The gene discussed is BTK; the disease is Bruton-type agammaglobulinemia.